Dexmedetomidine for the management of awake fibreoptic intubation
نویسندگان
چکیده
منابع مشابه
Awake fibreoptic intubation for airway burns.
A young adult was admitted to a casualty department with severe burns sustained in a motor vehicle fire. His airway was initially patient, but in grave danger of obstruction due to inhalational injury. Conventional methods of airway management were unable to guarantee a patent airway and a novel approach is described.
متن کاملDexmedetomidine and low-dose ketamine provide adequate sedation for awake fibreoptic intubation.
PURPOSE We report the use of the alpha2 agonist, dexmedetomidine, with low-dose ketamine as a safe and effective treatment strategy to provide adequate comfort and sedation for a patient who fulfilled criteria of a difficult airway and required awake fibreoptic intubation (AFOI). CLINICAL FEATURES A 52-yr-old male with prostate cancer presented for radical prostatectomy. He reported several f...
متن کاملDexmedetomidine as sole sedative for awake intubation in management of the critical airway.
We report a series of successful awake fiberoptic intubations in patients with critical (unstable, difficult) airways using the alpha(2)-agonist, dexmedetomidine. Dexmedetomidine has several desirable pharmacologic properties, including sedation, anxiolysis, hypnosis, analgesia, amnesia, antisialagogue effects, and a unique respiratory-sparing effect. Dexmedetomidine appears to be a useful agen...
متن کاملDexmedetomidine for conscious sedation in difficult awake fiberoptic intubation cases.
Currently used methods of sedation for fiberoptic intubation such as benzodiazepines, propofol, or opioids have their limitations. Dexmedetomidine (DEX) is a selective alpha-2 adrenergic agonist that has been used clinically for its sympatholytic, analgesic, and sedative properties. We report on 4 patients with particularly difficult airways who underwent successful awake fiberoptic intubation ...
متن کاملDexmedetomidine versus Remifentanil for Sedation during Awake Fiberoptic Intubation
This study compared remifentanil and dexmedetomidine as awake fiberoptic intubation (AFOI) anesthetics. Thirty-four adult ASA I-III patients were enrolled in a double-blinded randomized pilot study to receive remifentanil (REM) or dexmedetomidine (DEX) for sedation during AFOI (nasal and oral). Thirty patients completed the study and received 2 mg midazolam IV and topical anesthesia. The REM gr...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cochrane Database of Systematic Reviews
سال: 2014
ISSN: 1465-1858
DOI: 10.1002/14651858.cd009798.pub2